The latest out of global pharmaceutical giant Eli Lilly and Co. CEO Dave Ricks joins us for perspective on the post-COVID workforce, the company’s drug pipeline and potential for future growth.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}